Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effect of calcitonin on bone mass and fracture rates.

Literature DB >> 1750411

Effect of calcitonin on bone mass and fracture rates.

J Y Reginster¹.

Abstract

Entities: Disease

Mesh：

Substances：
Calcitonin

Year: 1991 PMID： 1750411 DOI： 10.1016/0002-9343(91)90242-p

Source DB: PubMed Journal: Am J Med ISSN： 0002-9343 Impact factor: 4.965

Keyword Cloud
Cited

× No keyword cloud information.

11 in total

1. Efficacy and harms of nasal calcitonin in improving bone density in young patients with inflammatory bowel disease: a randomized, placebo-controlled, double-blind trial.

Authors: Helen M Pappa; Tracee M Saslowsky; Rajna Filip-Dhima; Diane DiFabio; Hajar Hassani Lahsinoui; Apurva Akkad; Richard J Grand; Catherine M Gordon
Journal: Am J Gastroenterol Date: 2011-04-26 Impact factor: 10.864

Review 2. Evidence-based guidelines for the treatment of postmenopausal osteoporosis: a consensus document of the Belgian Bone Club.

Authors: Steven Boonen; Jean-Jacques Body; Yves Boutsen; Jean-Pierre Devogelaer; Stefan Goemaere; Jean-Marc Kaufman; Serge Rozenberg; Jean-Yves Reginster
Journal: Osteoporos Int Date: 2005-01-26 Impact factor: 4.507

3. The effect of intranasal salmon calcitonin on postmenopausal bone turnover as assessed by biochemical markers: evidence of maximal effect after 8 weeks of continuous treatment.

Authors: M E Kraenzlin; M J Seibel; U Trechsel; V Boerlin; M Azria; C A Kraenzlin; H G Haas
Journal: Calcif Tissue Int Date: 1996-04 Impact factor: 4.333

Review 4. Calcitonin in the treatment of osteoporosis.

Authors: C Gennari; A Camporeale
Journal: Osteoporos Int Date: 1997 Impact factor: 4.507

5. Cost effectiveness of nasal calcitonin in postmenopausal women: use of Cochrane Collaboration methods for meta-analysis within economic evaluation.

Authors: D Coyle; A Cranney; K M Lee; V Welch; P Tugwell
Journal: Pharmacoeconomics Date: 2001 Impact factor: 4.981

Effect of calcitonin on bone mass and fracture rates.

1. Efficacy and harms of nasal calcitonin in improving bone density in young patients with inflammatory bowel disease: a randomized, placebo-controlled, double-blind trial.

Review 2. Evidence-based guidelines for the treatment of postmenopausal osteoporosis: a consensus document of the Belgian Bone Club.

3. The effect of intranasal salmon calcitonin on postmenopausal bone turnover as assessed by biochemical markers: evidence of maximal effect after 8 weeks of continuous treatment.

Review 4. Calcitonin in the treatment of osteoporosis.

5. Cost effectiveness of nasal calcitonin in postmenopausal women: use of Cochrane Collaboration methods for meta-analysis within economic evaluation.

6. Salmon calcitonin nasal spray : An effective alternative to estrogen therapy in select postmenopausal women.

7. Prevention of postmenopausal bone loss by rectal calcitonin.

Review 8. Management of osteoporosis and Paget's disease. An appraisal of the risks and benefits of drug treatment.

9. Sustained release of salmon calcitonin in vivo from lactide: glycolide copolymer depots.

Review 10. European guidance for the diagnosis and management of osteoporosis in postmenopausal women.